Maria Sharapova is suspended from tennis after failing drugs test Continued




‘I am still working through my injury and that is the reason I withdrew from Palm Springs, because I have still not healed my injury.

Asked if she knew what the consequences of her failed test may be, Sharapova added: ‘I do not. This is very new for me, I just received the letter a few days ago and I will be working with the ITF.’

The full statement from the ITF made clear Sharapova accepted the charge against her.

It said: ‘Following the statement made by Maria Sharapova in a press conference today, the Tennis Anti-Doping Programme (TADP) can confirm the following:

31F7813F00000578-3480964-image-a-125_1457384339473

On 26 January 2016, Ms Sharapova provided an anti-doping sample to the TADP in association with her participation in the 2016 Australian Open.

‘That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory, which returned a positive for meldonium, which is a prohibited substance under the WADA Code and, therefore also the TADP.

‘In accordance with Article 8.1.1 of the TADP, Ms Sharapova was charged on 2 March with an Anti-Doping Rule Violation.

‘Ms Sharapova has accepted the finding of meldonium in her sample collected on 26 January.

‘As meldonium is a non-specified substance under the WADA (and, therefore, TADP) list of Prohibited Substances and Prohibited Methods, Ms Sharapova will be provisionally suspended with effect from 12 March, pending determination of the case.’

Related Post

Share ThisEmail this to someonePin on PinterestPrint this pageShare on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Comments

comments

Be the first to comment

Leave a Reply

Facebook
Get More News and Stories Like This In Your Email
We respect your privacy.
%d bloggers like this: